U.S. flag

An official website of the United States government

NM_007194.4(CHEK2):c.154T>A (p.Ser52Thr) AND Familial cancer of breast

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Jan 20, 2019
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001058867.9

Allele description [Variation Report for NM_007194.4(CHEK2):c.154T>A (p.Ser52Thr)]

NM_007194.4(CHEK2):c.154T>A (p.Ser52Thr)

Gene:
CHEK2:checkpoint kinase 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
22q12.1
Genomic location:
Preferred name:
NM_007194.4(CHEK2):c.154T>A (p.Ser52Thr)
HGVS:
  • NC_000022.11:g.28734568A>T
  • NG_008150.2:g.12299T>A
  • NM_001005735.2:c.154T>A
  • NM_001257387.2:c.-624T>A
  • NM_001349956.2:c.154T>A
  • NM_007194.4:c.154T>AMANE SELECT
  • NM_145862.2:c.154T>A
  • NP_001005735.1:p.Ser52Thr
  • NP_001336885.1:p.Ser52Thr
  • NP_009125.1:p.Ser52Thr
  • NP_665861.1:p.Ser52Thr
  • LRG_302t1:c.154T>A
  • LRG_302:g.12299T>A
  • LRG_302p1:p.Ser52Thr
  • NC_000022.10:g.29130556A>T
  • NG_008150.1:g.12267T>A
  • NM_007194.3:c.154T>A
Protein change:
S52T
Links:
dbSNP: rs2054325597
NCBI 1000 Genomes Browser:
rs2054325597
Molecular consequence:
  • NM_001257387.2:c.-624T>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001005735.2:c.154T>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001349956.2:c.154T>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_007194.4:c.154T>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_145862.2:c.154T>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Familial cancer of breast
Synonyms:
Breast cancer, familial; Hereditary breast cancer
Identifiers:
MONDO: MONDO:0016419; MedGen: C0346153; OMIM: 114480

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV001223464Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))		Uncertain significance
(Jan 20, 2019) 		germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001223464.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

This sequence change replaces serine with threonine at codon 52 of the CHEK2 protein (p.Ser52Thr). The serine residue is moderately conserved and there is a small physicochemical difference between serine and threonine. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals with CHEK2-related conditions. This variant is not present in population databases (ExAC no frequency).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024